Is the Protein-Mediated Uptake of Drugs by Organic Anion Transporting Polypeptides a Real Phenomenon or an Artifact?-Reference-Cited by-同舟云学术

Is the Protein-Mediated Uptake of Drugs by Organic Anion Transporting Polypeptides a Real Phenomenon or an Artifact?

Published:2022-03-29 Issue:9 Volume:50 Page:1132-1141
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Yin Mengyue,Storelli Flavia,Unadkat Jashvant D.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference35 articles.

1. Baik J Huang Y (2015) Transporter-induced protein binding shift (TIPBS): hypothesis and modeling, in ISSX Online Abstracts from 20th North American ISSX Meeting ; 2015 Oct 18–22; Orlando, FL. Suppl 10 (No. 2):P272, International Society for the Study of Xenobiotics, Washington, DC.

2. Effect of Human Plasma on Hepatic Uptake of Organic Anion–Transporting Polypeptide 1B Substrates: Studies Using Transfected Cells and Primary Human Hepatocytes

3. Positron emission tomography imaging of [11C]rosuvastatin hepatic concentrations and hepatobiliary transport in humans in the absence and presence of cyclosporin A;Billington;Clin Pharmacol Ther,2019

4. Binding of rifampicin by human plasma proteins

5. Hepatic Clearance Predictions from In Vitro-In Vivo Extrapolation and the Biopharmaceutics Drug Disposition Classification System

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Albumin-Mediated Drug Uptake by Organic Anion Transporter 1/3 Is Real: Implications for the Prediction of Active Renal Secretion Clearance;Molecular Pharmaceutics;2024-08-21

2. Physiologically Based Pharmacokinetic Model of OATP1B Substrates with a Nonlinear Mixed Effect Approach: Estimating Empirical In Vitro-to-In Vivo Scaling Factors;Clinical Pharmacokinetics;2024-08

3. Survey of Pharmaceutical Industry’s Best Practices around In Vitro Transporter Assessment and Implications for Drug Development: Considerations from the International Consortium for Innovation and Quality for Pharmaceutical Development Transporter Working Group;Drug Metabolism and Disposition;2024-05-02

4. Using the Dynamic Well-Stirred Model to Extrapolate Hepatic Clearance of Organic Anion-Transporting Polypeptide Transporter Substrates without Assuming Albumin-Mediated Hepatic Drug Uptake;Drug Metabolism and Disposition;2024-04-11

5. Novel method of measurement of in vitro drug uptake in OATP1B3 overexpressing cells in the presence of dextran;Pharmacological Reports;2024-03-26